- 山河药辅 (300452)- 投资活动产生的现金流量

现金流分析步骤二:分析 投资活动 产生的现金流量

现金及等价物净增加额

-0.3亿    ,0.0,-0.4,0.1,0.1,0.3,-0.0,0.3,-0.3
了解明细
期初现金及等价物余额

1.5亿    ,1.2,1.2,0.8,0.9,1.0,1.2,1.2,1.5
了解明细
期末现金及等价物余额

1.2亿    ,1.2,0.8,0.9,1.0,1.2,1.2,1.5,1.2
了解明细


经营活动现金流净额

0.2亿    ,0.6,0.7,0.8,0.9,1.0,1.3,1.3,0.2
了解明细
投资活动现金流净额

0.2亿    ,-0.3,-0.9,-0.3,-0.9,-0.2,-0.9,-3.3,0.2
了解明细
筹资活动现金流净额

-0.8亿    ,-0.3,-0.2,-0.4,0.1,-0.6,-0.5,2.3,-0.8
了解明细
汇率变动对现金影响

0.0亿    ,0.0,0,0,-0.0,-0.0,0.0,-0.0,0.0
了解明细


投资活动现金流出小计

6.0亿    ,7.1,7.7,5.7,4.5,3.6,4.5,8.0,6.0
了解明细
投资活动现金流入小计

6.1亿    ,6.8,6.8,5.4,3.7,3.4,3.6,4.7,6.1
了解明细
投资支付的现金

5.8亿    ,6.1,6.9,5.1,4.3,3.3,3.8,7.4,5.8
了解明细
收回投资收到的现金

5.9亿    ,6.7,6.7,5.4,3.6,3.4,3.5,4.5,5.9
了解明细
购建资产支付的现金

0.2亿    ,0.3,0.8,0.6,0.2,0.3,0.7,0.5,0.2
了解明细
出售资产收回的现金

0.0亿    ,0.0,0.0,0.0,-0.0,0.0,0.0,0.0,0.0
了解明细
取得子公司支付的现金

0亿    ,0.7,0,0,0,0,0,0,0
了解明细
处置子公司收到的现金

0亿    ,0,0,0,0,0,0,0,0
了解明细
支付其他投资有关的现金

0.0亿    ,0.0,0.0,0.0,0.0,0.0,-0.0,0.0,0.0
了解明细
收到其他投资有关的现金

0亿    ,0.0,0.0,0.0,0,0,0,0,0
了解明细
取得投资收益的现金

0.2亿    ,0.0,0.1,0.0,0.0,0.1,0.1,0.1,0.2
了解明细